Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Mar 26;20(2):458–460.e4. doi: 10.1016/j.cgh.2021.03.031

Figure 1b.

Figure 1b.

Multivariate model showing odds of statin use in TARGET-NASH patients with indications for statin therapy.

Effect estimates are adjusted for all other variables in the model.

Abbreviations: atherosclerotic cardiovascular disease (ASCVD), body mass index (BMI), history (Hx), lower and upper confidence limits (LCL and UCL), milligrams per deciliter (mg/dL), type 2 diabetes mellitus (T2DM)